Medicago

• Governments seek buyer as Quebec COVID-19 vaccine manufacturer Medicago set to close

  Pierre Fitzgibbon said the province has had preliminary talks with potential buyers in the pharmaceutical sector to keep Medicago's expertise and skilled workforce in Quebec.

  Canada

  Feb 3
  
• Medicago to cease operations in Quebec, scuttling COVID-19 vaccine production plans

  Medicago has shut down its COVID-19 vaccine project in Quebec after its sole shareholder decided to no longer invest in the company, the company announced Thursday.

  Health

  Feb 2
  
• Advertisement
• Quebec says mRNA COVID-19 vaccines preferable to Medicago in most circumstances

  Quebec's immunization committee recommends the two-dose vaccine be used for those aged 18 to 64 who are unable to get an mRNA vaccine or have fears about using them.

  Health

  Apr 19, 2022
• Advertisement
• Canada wants WHO to approve Medicago’s COVID vaccine so it can be donated: Sajjan

  International Development Minister Harjit Sajjan says he wants the WHO to greenlight Medicago's COVID-19 shot so it can be donated and used by the COVAX vaccine-sharing alliance.

  Health

  Mar 21, 2022
• Medicago’s Canada-made COVID-19 vaccine faces WHO rejection due to tobacco industry ties

  Dr. Mariângela Simão, WHO's assistant director-general for access to medicines and health products, spoke about the vaccine during a press briefing Wednesday.

  Health

  Mar 17, 2022
• Canadian manufacturer Medicago’s COVID-19 vaccine showing strong efficacy

  Medicago announced clinical results that shows 88 per cent efficacy against the Gamma variant and more than 75 per cent efficacy against the Delta variant of COVID-19.

  Health

  Dec 7, 2021
• Medicago clinical trial participants want equal access to Quebec COVID-19 vaccine passport

  On Tuesday, health officials, including the province's director of public health, Dr. Horacio Arruda, indicated they may cut the participants some slack.

  Health

  Aug 26, 2021
• Canada’s Medicago says its COVID-19 vaccine shows promising antibody results in trial

  Medicago said a Phase 2 clinical trial involving hundreds of participants found the vaccine appears to produce 10 times the antibodies as are seen in people who have had COVID-19.

  Health

  May 18, 2021
• Advertisement
• Canada’s Medicago begins late-stage study of COVID-19 vaccine with GlaxoSmithKline

  Medicago, which has Canada's most advanced COVID-19 vaccine project under development, expects to report results from a mid-stage trial of the vaccine in April.

  Canada

  Mar 16, 2021
• Advertisement
• Canada’s COVID-19 vaccine contender: Medicago’s breakthrough, ties to Big Tobacco and warnings a pandemic was coming

  For years Medicago said a pandemic was coming and we should be ready. Today, it is a leading contender to create a made-in-Canada COVID-19 vaccine.

  Features

  Jan 11, 2021